Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Expanded carrier screening and preimplantation genetic diagnosis in a couple who delivered a baby affected with congenital factor VII deficiency.

He WB, Tan YQ, Hu X, Li W, Xiong B, Luo KL, Gong F, Lu GX, Lin G, Du J.

BMC Med Genet. 2018 Jan 24;19(1):15. doi: 10.1186/s12881-018-0525-9.

2.

Genotype and phenotype correlation in intracranial hemorrhage in neonatal factor VII deficiency among Thai children.

Traivaree C, Monsereenusorn C, Meekaewkunchorn A, Laoyookhong P, Suwansingh S, Boonyawat B.

Appl Clin Genet. 2017 Jun 21;10:37-41. doi: 10.2147/TACG.S139788. eCollection 2017.

3.

Recombinant Factor VIIa Use for Endoscopic Retrograde Cholangiopancreatography With Sphincterotomy in a Patient With Choledocholithiasis and Unusual Coagulopathy.

Abdulsamad M, Reddy P, Guvvala S, Dev A.

Gastroenterology Res. 2017 Apr;10(2):144-146. doi: 10.14740/gr812w. Epub 2017 Apr 19.

4.

Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding Disorders.

Castaman G, Linari S.

J Clin Med. 2017 Apr 10;6(4). pii: E45. doi: 10.3390/jcm6040045. Review.

5.

Factor VII Deficiency: Clinical Phenotype, Genotype and Therapy.

Napolitano M, Siragusa S, Mariani G.

J Clin Med. 2017 Mar 28;6(4). pii: E38. doi: 10.3390/jcm6040038. Review.

6.

Thrombosis in a bleeding disorder: case of thromboembolism in factor VII deficiency.

Ramdass SK, Loh KP, Howard LM.

Clin Case Rep. 2017 Feb 1;5(3):277-279. doi: 10.1002/ccr3.836. eCollection 2017 Mar.

7.

Anticoagulation Therapy Considerations in Factor VII Deficiency.

Paulus E, Komperda K, Park G, Fusco J.

Drug Saf Case Rep. 2016 Dec;3(1):8.

8.

An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes.

Barbon E, Pignani S, Branchini A, Bernardi F, Pinotti M, Bovolenta M.

Sci Rep. 2016 Jun 24;6:28304. doi: 10.1038/srep28304.

9.
10.

Heterozygous congenital Factor VII deficiency with the 9729del4 mutation, associated with severe spontaneous intracranial bleeding in an adolescent male.

Cramer TJ, Anderson K, Navaz K, Brown JM, Mosnier LO, von Drygalski A.

Blood Cells Mol Dis. 2016 Mar;57:8-12. doi: 10.1016/j.bcmd.2015.11.004. Epub 2015 Nov 10.

11.

Successful management of maternal factor VII deficiency in a cesarean section.

Lee YJ, Ju DH, Yi SW, Lee SS, Sohn WS.

Obstet Gynecol Sci. 2014 Jul;57(4):314-7. doi: 10.5468/ogs.2014.57.4.314. Epub 2014 Jul 15.

12.

Is prophylaxis required for delivery in women with factor VII deficiency?

Baumann Kreuziger LM, Morton CT, Reding MT.

Haemophilia. 2013 Nov;19(6):827-32. doi: 10.1111/hae.12167. Epub 2013 Apr 22. Review.

13.

Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven(®)).

Bartosh NS, Tomlin T, Cable C, Halka K.

Clin Pharmacol. 2013;5:53-8. doi: 10.2147/CPAA.S39772. Epub 2013 Mar 15.

14.

Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER).

Napolitano M, Giansily-Blaizot M, Dolce A, Schved JF, Auerswald G, Ingerslev J, Bjerre J, Altisent C, Charoenkwan P, Michaels L, Chuansumrit A, Di Minno G, Caliskan U, Mariani G.

Haematologica. 2013 Apr;98(4):538-44. doi: 10.3324/haematol.2012.074039. Epub 2013 Feb 12.

15.

Surgery in patients with congenital factor VII deficiency: A single center experience.

Kim SH, Park YS, Kwon KH, Lee JH, Kim KC, Yoo MC.

Korean J Hematol. 2012 Dec;47(4):281-5. doi: 10.5045/kjh.2012.47.4.281. Epub 2012 Dec 24.

16.

Activation of a cryptic splice site in a potentially lethal coagulation defect accounts for a functional protein variant.

Cavallari N, Balestra D, Branchini A, Maestri I, Chuamsunrit A, Sasanakul W, Mariani G, Pagani F, Bernardi F, Pinotti M.

Biochim Biophys Acta. 2012 Jul;1822(7):1109-13. doi: 10.1016/j.bbadis.2012.03.001. Epub 2012 Mar 9.

17.

Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency.

Branchini A, Rizzotto L, Mariani G, Napolitano M, Lapecorella M, Giansily-Blaizot M, Mari R, Canella A, Pinotti M, Bernardi F.

Haematologica. 2012 May;97(5):705-9. doi: 10.3324/haematol.2011.049403. Epub 2011 Dec 16.

18.

Canine specific ELISA for coagulation factor VII.

Knudsen T, Kjelgaard-Hansen M, Tranholm M, Wiinberg B, Clausen JT, Hansen JJ, Nichols TC, Kjalke M, Jensen AL, Kristensen AT.

Vet J. 2011 Dec;190(3):352-8. doi: 10.1016/j.tvjl.2010.11.010. Epub 2011 Jan 8.

19.

A case of intracranial hemorrhage in a neonate with congenital factor VII deficiency.

Lee WS, Park YS.

Korean J Pediatr. 2010 Oct;53(10):913-6. doi: 10.3345/kjp.2010.53.10.913. Epub 2010 Oct 31.

20.

Evidence for an overlapping role of CLOCK and NPAS2 transcription factors in liver circadian oscillators.

Bertolucci C, Cavallari N, Colognesi I, Aguzzi J, Chen Z, Caruso P, Foá A, Tosini G, Bernardi F, Pinotti M.

Mol Cell Biol. 2008 May;28(9):3070-5. doi: 10.1128/MCB.01931-07. Epub 2008 Mar 3.

Supplemental Content

Support Center